Author: Kent, A. C. C.; Cross, G.; Taylor, D. R.; Sherwood, R. A.; Watson, P. J.
Title: Measurement of serum 7a-hydroxy-4-cholesten-3-one as a marker of bile acid malabsorption in dogs with chronic diarrhoea: a pilot study Document date: 2016_4_6
ID: rkdfde07_26
Snippet: In conclusion, this study suggests that C4 measurement is feasible in dogs and may indicate the presence FIG 2: A receiver operating characteristic (ROC) curve for various cut-off levels of serum C4 concentration demonstrating the sensitivity and specificity for the presumed diagnosis of bile acid malabsorption of bile acid malabsorption in some cases. Assuming that bile acid malabsorption occurs in cases with elevated serum C4, 17.6 per cent (3/.....
Document: In conclusion, this study suggests that C4 measurement is feasible in dogs and may indicate the presence FIG 2: A receiver operating characteristic (ROC) curve for various cut-off levels of serum C4 concentration demonstrating the sensitivity and specificity for the presumed diagnosis of bile acid malabsorption of bile acid malabsorption in some cases. Assuming that bile acid malabsorption occurs in cases with elevated serum C4, 17.6 per cent (3/17; 95 per cent CI 6.2 to 41.0 per cent) of the dogs with chronic diarrhoea in this study may have had bile acid malabsorption, similar to what has been found in people. However, larger studies are needed to define the true prevalence in dogs as the prevalence in this study is speculative. While further studies are needed to explore the clinical significance, clinicians should be aware of the potential for bile acid malabsorption in cases that are poorly responsive to conventional therapies.
Search related documents:
Co phrase search for related documents- clinical significance and conventional therapy: 1, 2
- clinical significance and cut level: 1, 2
- clinical significance and large study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- clinical significance and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- clinical significance and study prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- clinical significance and true prevalence: 1
- clinical significance explore and specificity sensitivity: 1, 2
- conventional therapy and large study: 1, 2
- conventional therapy and specificity sensitivity: 1, 2, 3
- cut level and large study: 1, 2
- cut level and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- cut level and study prevalence: 1
- large study and people find: 1
- large study and specificity sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- large study and study prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- people find and study prevalence: 1, 2
- specificity sensitivity and study prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- specificity sensitivity and true prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- study prevalence and true prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Co phrase search for related documents, hyperlinks ordered by date